Combining CagriSema (which contains semaglutide) with tirzepatide (which activates GLP-1 receptors) would result in excessive GLP-1 pathway stimulation, likely producing severe gastrointestinal side effects
Ginger and its ingredients regulate the Th-1, Th-2, Th-9, Th-17, Th-22, and Treg cell-related immune responses, down-regulating the B cell-related immune responses, modulate the macrophages-related responses, and the inflammatory mediator production and the adhesion molecules expression, interfere with the toll-like receptor (TLR)-related signaling pathways, suppress the inflammasomes and the oxidative stress (Jafarzadeh and Nemati, 2018)
10.3389/fphar.2022.946192 112 LiX
One user documented a harrowing experience wherein a mere nine-day cycle of a low dose (60 micrograms) of BPC-157 triggered a massive, acute autoimmune-like systemic reaction